Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medicinova (MNOV) Operating Expenses (2021 - 2025)

Medicinova (MNOV) has disclosed Operating Expenses for 8 consecutive years, with $4.2 million as the latest value for Q4 2025.

  • Quarterly Operating Expenses changed N/A to $4.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $14.6 million through Dec 2025, changed N/A year-over-year, with the annual reading at $13.7 million for FY2025, 8.03% up from the prior year.
  • Operating Expenses for Q4 2025 was $4.2 million at Medicinova, up from $3.5 million in the prior quarter.
  • The five-year high for Operating Expenses was $4.3 million in Q2 2021, with the low at $2.1 million in Q4 2021.
  • Average Operating Expenses over 5 years is $3.4 million, with a median of $3.4 million recorded in 2022.
  • The sharpest move saw Operating Expenses tumbled 44.92% in 2023, then surged 54.14% in 2024.
  • Over 5 years, Operating Expenses stood at $2.1 million in 2021, then soared by 85.34% to $3.9 million in 2022, then tumbled by 36.11% to $2.5 million in 2023, then skyrocketed by 32.89% to $3.3 million in 2024, then rose by 26.95% to $4.2 million in 2025.
  • According to Business Quant data, Operating Expenses over the past three periods came in at $4.2 million, $3.5 million, and $3.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.